Search Bar & Filters
Found 6 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting a prospective, longitudinal natural history study to better understand Angelman syndrome in children and adults. The study aims to collect detailed data through both investigator observations and reports from parents. This information will help establish Angelman syndrome-specific norms for outcome measures, supporting the design of future clinical trials and improving care for those affected by the condition. This observational study does not involve any treatments or interventions. Instead, participants will be followed over time to gather information about their medical history and development. The study collects data through various assessments including the Vineland Adaptive Behavior Scales, Bayley Scales of Infant and Toddler Development, and the Observer-Reported Communication Ability Measure, conducted over an average period of one year. Participants will be involved in regular evaluations that include medical history reviews and developmental assessments. These assessments provide valuable information on communication abilities and adaptive behaviors. The study is sponsored by Boston Childrens Hospital and will continue through April 2031. The collected data aims to support future research and enhance understanding of Angelman syndromes progression and care needs.
Actively Recruiting
Researchers are evaluating obudanersen in people with Angelman syndrome AS caused by paternal uniparental disomy or imprinting defects. This Phase 3 study aims to assess the treatments effect on expressive communication in children and adults with AS, focusing on those aged 2 to 50 years. The study is open-label with a single treatment group and includes two age-based cohorts, with more participants expected in the pediatric group. Participants receive obudanersen through an injection into the spinal fluid every 12 weeks during two main periods a Treatment Evaluation Period lasting about 60 weeks, followed by a Long-Term Extension period of 101 weeks. After these, there is an 8-month Post-Treatment Follow-up phase. The study involves intrathecal bolus injections at regular intervals throughout these periods. During the study, participants will undergo various assessments including expressive communication evaluations using the Bayley Scales for Infant and Toddler Development and other behavior and adaptive skill measures at baseline and week 52. Caregiver-reported outcomes and clinical evaluations will monitor progress and safety. The total involvement spans multiple years, including treatment, long-term extension, and follow-up to thoroughly assess the treatment impact and safety over time.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a patient navigation program designed to increase access to lung cancer screening LCS for individuals meeting current screening guidelines. This single-arm study focuses on patients who identify as Black or African-American with a significant smoking history and aims to improve the proportion of patients completing low dose computed tomography LDCT screening. Participants will receive support from trained centralized patient navigators who assist with clinical, logistical, and financial barriers to screening. The navigation is personalized to each participant and addresses individual, organizational, economic, and sociocultural challenges. Follow-up visits are provided as needed to help participants overcome these obstacles and complete screening. During the study, participants will undergo assessments of feasibility, acceptability, health-related quality of life, and financial distress at the start and throughout the navigation period, which may last from 2 weeks up to 10 months. The main outcome is the completion of lung cancer screening. Participants are involved in navigation activities and assessments, with safety and progress monitored by the research team throughout the study duration.
Actively Recruiting
Researchers are evaluating a remote, non-drug program called Regulating Together RT to help children and adolescents with Tuberous Sclerosis Complex TSC and related neuropsychiatric challenges manage symptoms of emotion dysregulation. The study focuses on improving emotional control in young participants aged 8 to 17 years with behavioral symptoms linked to TSC. This pilot feasibility trial includes children diagnosed clinically or genetically with TSC who show behavioral issues such as temper tantrums, aggression, self-injury, or impulsivity. The study consists of several phases over 22 weeks. It starts with a single in-person screening and baseline visit, followed by a 5-week control phase without intervention. Then, participants receive an intensive RT program involving small group behavioral therapy sessions twice a week for 5 weeks, conducted remotely by trained psychologists. Caregivers attend separate but parallel sessions. After this, there is a one-time individualized consultation with a psychologist. Finally, participants practice the learned skills at home during a 10-week follow-up, ending with a final interview to explore factors affecting the intervention. Throughout the study, parents complete assessments measuring emotional and behavioral changes at each phase, including tools like the Emotion Dysregulation Inventory and other behavior rating scales. The study team measures changes in emotional dysregulation from baseline through intervention and follow-up. Participants need access to video-capable devices and internet for remote sessions. Researchers monitor progress through questionnaires, interviews, and behavioral observations, aiming to understand how well the RT program supports emotional regulation in children with TSC.
Actively Recruiting
Researchers are investigating whether telehealth-based Family Navigation can speed up enrollment in community-based autism intervention programs for toddlers under 4 years old living in rural North Carolina after their recent autism diagnosis. The study aims to find out if this navigation support reduces the time to start intervention, improves developmental progress at 18 months post-diagnosis, and enhances caregiver well-being compared to usual care. Participants are randomly assigned to one of two groups. One group receives up to four virtual sessions with a trained navigator who helps caregivers identify and enroll in recommended early intervention services. The other group, serving as a comparison, receives educational materials about early intervention and community supports at four timepoints during the first three months after joining the study. Throughout the study, caregivers and children will be monitored for time to intervention start, developmental changes, and caregiver well-being. Developmental outcomes are assessed at baseline and 18 months post-diagnosis using standardized measures, while caregiver well-being is measured at six months. The study lasts up to 18 months post-diagnosis, with all contact and assessments conducted virtually to suit the rural setting.
Actively Recruiting
Researchers are evaluating a telehealth intervention called Surviving and Thriving in the Real World - Telehealth STRW-T for autistic adolescents in their last two years of high school. This study compares STRW-T, which targets daily living skills, to a control telehealth intervention called Program for the Education and Enrichment of Relational Skills - Telehealth PEERS-T that focuses on social skills. The goal is to assess changes in daily living skills and related outcomes to support successful transition to adulthood for adolescents with high functioning autism spectrum disorder ASD. The study involves 192 autistic adolescents aged 15 to 21 who are randomized to either the STRW-T group or the PEERS-T control group, with 96 participants in each arm. STRW-T consists of 15 weekly sessions delivered via Zoom, including caregiver group sessions and caregiver-teen dyad sessions focusing on daily living skills like morning routine, laundry, cooking, shopping, and money management. PEERS-T also runs for 15 weeks with concurrent caregiver and teen telehealth sessions targeting social skills development. Both interventions are designed to be meaningful and matched in duration. Participants will be assessed at baseline, after treatment, at 6-month follow-up, and 6 months post-high school graduation. Evaluations include standardized measures of daily living skills such as the Vineland Adaptive Behavior Scales and Adaptive Behavior Assessment System. The study also tracks college, employment, and quality of life outcomes after graduation. Caregiver input and daily diaries help monitor progress, with safety and mental health monitored throughout the study. Participation spans approximately 1.5 years to capture both immediate and longer-term effects of the interventions.